Dolby Laboratories (NYSE:DLB) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Dolby Laboratories (NYSE:DLB) issued its quarterly earnings results on Thursday. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.31 by $0.06, FiscalAI reports. Dolby Laboratories had a return on equity of 11.48% and a net margin of 17.85%.The business had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. During the same quarter in the prior year, the firm posted $1.34 earnings per share. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. Dolby Laboratories updated its FY 2026 guidance to 4.300-4.450 EPS and its Q3 2026 guidance to 0.560-0.710 EPS.

Here are the key takeaways from Dolby Laboratories’ conference call:

• Q2 results met company guidance with $396M revenue and $1.37 non?GAAP EPS; management reaffirmed full?year guidance of $1.4B–$1.45B revenue and $4.30–$4.45 EPS while reporting $93M operating cash flow, a $65M buyback and ~$675M cash and investments.
• Broad content adoption is accelerating demand — major social platforms (Meta, Douyin), top music artists, marquee sports events (Super Bowl, Olympics, F1) and the top domestic films are streaming or produced in Dolby Atmos and Dolby Vision, supporting device and platform adoption.
• Automotive is a notable growth driver with wins from BMW, BYD (Denza), Lexus, NIO and Hyundai’s IONIQ (4?channel Atmos), and the company says it is moving from premium to deeper, mass?market vehicle lineups.
• New monetization initiatives — the Video Distribution patent pool now includes ~40 licensors and a growing licensee pipeline, and Dolby OptiView added customers (Genius Sports, William Hill) targeting personalized live sports experiences, but these programs are early in commercial ramp.
• Macro and product?mix headwinds persist — memory pricing and timing affected mobile and PC (mobile down 6% this quarter), contributing to quarterly volatility even though management expects mid?single?digit full?year growth in those end markets.

Dolby Laboratories Trading Down 10.4%

Shares of NYSE DLB traded down $6.66 during mid-day trading on Friday, reaching $57.48. 2,137,252 shares of the company’s stock were exchanged, compared to its average volume of 482,138. The firm has a market capitalization of $5.49 billion, a price-to-earnings ratio of 23.18 and a beta of 0.86. The business has a fifty day simple moving average of $62.58 and a 200 day simple moving average of $64.55. Dolby Laboratories has a twelve month low of $55.73 and a twelve month high of $78.28.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be given a dividend of $0.36 per share. The ex-dividend date of this dividend is Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.5%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 58.06%.

Key Dolby Laboratories News

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Q2 results topped Street estimates — Dolby reported EPS of $1.37 and revenue of roughly $395.6M, driven by licensing strength, higher broadcast demand and continued Dolby Atmos adoption. This topline beat supports near?term growth narratives. Dolby Q2 Earnings Top Estimates on Licensing Strength, Revenues Up Y/Y
• Positive Sentiment: Management raised FY?2026 outlook — Dolby lifted full?year EPS guidance to $4.30–$4.45 (above consensus) and gave a revenue range that implies mid?single?digit growth for the year, supporting longer?term earnings expectations. Dolby Laboratories Reports Second Quarter 2026 Financial Results
• Neutral Sentiment: Quarterly dividend declared — Dolby set a $0.36 quarterly dividend (yield ~2.5%), payable May 20 with an ex?dividend date of May 12. This supports income investors but is expected and not a surprise.
• Neutral Sentiment: Earnings materials available — The full earnings release and call transcript are published for more detail on segment trends, customer wins and product adoption; useful for digging into assumptions behind guidance. Dolby Q2 2026 Earnings Call Transcript
• Negative Sentiment: Weak Q3 guidance drove the sell?off — Dolby guided Q3 EPS of $0.56–$0.71 and revenue of $295–$325M, both materially below consensus (Q3 revenue guidance ~ $343M and EPS ~ $0.92), signaling near?term demand variability and prompting investor concern.
• Negative Sentiment: Cash?flow and other operational flags — Third?party summaries highlighted a sharp drop in operating cash flow year?over?year and a modest decline in cash balances, raising questions about near?term cash generation despite GAAP profitability. Dolby Laboratories (DLB) Stock Falls on Q2 2026 Earnings
• Negative Sentiment: Insider and institutional activity noted — Recent reporting flagged substantial insider selling and some large institutional position reductions, which can add downward pressure on sentiment if sustained. Dolby Laboratories (DLB) Stock Falls on Q2 2026 Earnings

Analyst Ratings Changes

DLB has been the topic of a number of recent analyst reports. Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a report on Monday, April 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Rosenblatt Securities restated a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a report on Friday, January 30th. Finally, Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.

Insider Transactions at Dolby Laboratories

In other news, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total transaction of $198,420.00. Following the sale, the senior vice president owned 83,218 shares of the company’s stock, valued at $5,504,038.52. This trade represents a 3.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Ryan Nicholson sold 2,667 shares of the firm’s stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $66.38, for a total value of $177,035.46. Following the sale, the chief accounting officer directly owned 36,956 shares in the company, valued at approximately $2,453,139.28. This represents a 6.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 37.93% of the company’s stock.

Institutional Investors Weigh In On Dolby Laboratories

A number of hedge funds have recently modified their holdings of the business. Boothbay Fund Management LLC raised its position in shares of Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after purchasing an additional 157 shares during the period. Raymond James Financial Inc. raised its position in shares of Dolby Laboratories by 1.0% during the second quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock worth $1,808,000 after purchasing an additional 235 shares during the period. Cresset Asset Management LLC raised its position in Dolby Laboratories by 10.7% in the 3rd quarter. Cresset Asset Management LLC now owns 2,991 shares of the electronics maker’s stock valued at $216,000 after buying an additional 290 shares during the last quarter. US Bancorp DE raised its position in Dolby Laboratories by 31.3% in the 3rd quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock valued at $103,000 after buying an additional 341 shares during the last quarter. Finally, Cetera Investment Advisers raised its position in Dolby Laboratories by 7.8% in the 4th quarter. Cetera Investment Advisers now owns 5,783 shares of the electronics maker’s stock valued at $371,000 after buying an additional 418 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.